NASDAQ:MYL - Mylan Stock Price, News, & Analysis

Mylan trades on the NASDAQ under the ticker symbol "MYL."

Mylan NV (NASDAQ:MYL) issued its earnings results on Tuesday, February, 26th. The company reported $1.30 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.36 by $0.06. The business had revenue of $3.04 billion for the quarter, compared to the consensus estimate of $3.10 billion. Mylan had a net margin of 3.08% and a return on equity of 19.06%. The firm's revenue for the quarter was down 4.8% compared to the same quarter last year. During the same period last year, the business posted $1.43 EPS. View Mylan's Earnings History.

Mylan is scheduled to release their next quarterly earnings announcement on Wednesday, May 8th 2019. View Earnings Estimates for Mylan.

Mylan issued an update on its FY19 earnings guidance on Tuesday, February, 26th. The company provided earnings per share (EPS) guidance of $3.80-4.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.02. The company issued revenue guidance of $11.5-12.5 billion, compared to the consensus revenue estimate of $11.87 billion.Mylan also updated its FY 2019 guidance to $3.80-4.80 EPS.

20 brokers have issued 12 month price targets for Mylan's stock. Their predictions range from $31.00 to $59.00. On average, they expect Mylan's stock price to reach $40.2222 in the next year. This suggests a possible upside of 52.1% from the stock's current price. View Analyst Price Targets for Mylan.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mylan in the last year. There are currently 5 hold ratings and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Mylan.

Headlines about MYL stock have trended somewhat negative on Wednesday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Mylan earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an impact on the company's share price in the near future.

Mylan saw a increase in short interest in March. As of March 15th, there was short interest totalling 11,829,580 shares, an increase of 62.9% from the February 28th total of 7,261,427 shares. Based on an average trading volume of 7,172,065 shares, the short-interest ratio is presently 1.6 days. Approximately 2.3% of the company's stock are sold short. View Mylan's Current Options Chain.

Some companies that are related to Mylan include Shire (SHPG), Zoetis (ZTS), Allergan (AGN), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Shiseido (SSDOY), Takeda Pharmaceutical (TKPYY), Alexion Pharmaceuticals (ALXN), Takeda Pharmaceutical (TAK), ASTELLAS PHARMA/ADR (ALPMY), Teva Pharmaceutical Industries (TEVA), BioMarin Pharmaceutical (BMRN), Ono Pharmaceutical (OPHLF), Merck KGaA (MKGAF) and GRIFOLS S A/S (GRFS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Mylan investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Alibaba Group (BABA), Allergan (AGN), Starbucks (SBUX), Micron Technology (MU), QUALCOMM (QCOM), General Electric (GE), Intel (INTC) and Celgene (CELG).

Mylan's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Harel Insurance Investments & Financial Services Ltd. (0.71%), Retirement Systems of Alabama (0.05%), RPG Investment Advisory LLC (0.04%), Strs Ohio (0.03%), Nisa Investment Advisors LLC (0.02%) and State of Alaska Department of Revenue (0.02%). Company insiders that own Mylan stock include Anthony Mauro, Heather M Bresch, Paul Campbell, Rajiv Malik and Robert J Coury. View Institutional Ownership Trends for Mylan.

MYL stock was sold by a variety of institutional investors in the last quarter, including Meeder Asset Management Inc., Strs Ohio, Virtu Financial LLC, Sumitomo Life Insurance Co., Bank of The West, Horan Capital Advisors LLC., Gateway Investment Advisers LLC and Kanawha Capital Management LLC. View Insider Buying and Selling for Mylan.

MYL stock was bought by a variety of institutional investors in the last quarter, including Harel Insurance Investments & Financial Services Ltd., Clear Harbor Asset Management LLC, Regent Investment Management LLC, Nisa Investment Advisors LLC, Investors Research Corp, RPG Investment Advisory LLC, State of Alaska Department of Revenue and Retirement Systems of Alabama. View Insider Buying and Selling for Mylan.

Shares of MYL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MYL stock can currently be purchased for approximately $26.45.

Mylan has a market capitalization of $13.65 billion and generates $11.43 billion in revenue each year. The company earns $352.50 million in net income (profit) each year or $4.58 on an earnings per share basis. Mylan employs 35,000 workers across the globe.

The official website for Mylan is http://www.mylan.com.

Mylan's mailing address is BUILDING 4 TRIDENT PLACE MOSQUITO WAY, HATFIELD X0, AL10 9UL. The company can be reached via phone at 44-0-17-0785-3000 or via email at [email protected]